Welcome to the international HTA database

Showing [23370 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Kidney transplantation following cardiocirculatory death: a review of the clinical evidence and guidelines
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Glycopyrronium bromide (Seebri® Breezhaler®) 44 micrograms inhalation powder as hard capsules
2013	Technology Assessment Unit of the McGill University Health Centre (MUHC)	The effectiveness and safety of rituximab (anti-CD20) in neurologic autoimmune diseases
2013	NIHR Health Technology Assessment programme	Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: a systematic review and economic evaluation
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-steroidal anti-inflammatory drugs for pain: a review of safety
2013	HAYES, Inc.	Autologous Stem Cell Transplantation (ASCT) for Metastatic Primitive Neuroectodermal Tumor (PNET)
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Quality of evidence in a systematic review on early skin-to-skin contact for mothers and their healthy newborn infants
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lymphatic-Venous anastomosis for lymphedema: clinical and cost-effectiveness
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Aztreonam lysine (Cayston®) 75 mg powder and solvent for nebuliser solution
2013	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Transcatheter aortic valve implantation (TAVI) in patients with aortic stenosis. Update of Report No. 45
2013	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2013	HAYES, Inc.	Automated percutaneous lumbar discectomy
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for initiating antiretroviral therapy in hospital inpatients with HIV
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Prostate cancer screening: a review of the guidelines
2013	Belgian Health Care Knowledge Centre (KCE)	Correction of refractive errors of the eye in adults – Part 2: laser surgery and intraocular lenses
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Urine drug screening in chronic pain patients on opioid therapy
2013	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Surgical aortic valve replacement with the ATS Enable® sutureless aortic valve for aortic stenosis
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Battery replacement and maintenance of deep brain stimulators: guidelines and recommendations
2013	HAYES, Inc.	Bilevel positive airway pressure for the treatment of obstructive sleep apnea in adults
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Thromboelastography-guided heparin use for the prevention of venous thromboembolism
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pain management for pediatric patients in the emergency department: guidelines
2013	Belgian Health Care Knowledge Centre (KCE)	Dissemination and implementation of clinical practice guidelines in Belgium
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Effects of non-steroidal anti-inflammatory drugs (NSAIDs) on bone fracture healing
2013	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Renal denervation for resistant hypertension
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Misoprostol administration for the treatment of post-partum uterine atony: clinical effectiveness, safety, and guidelines
2013	HAYES, Inc.	Biological mesh for abdominal hernia repair
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Antihistamine agents added to opioid analgesia
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bladder instillation of gentamicin for the treatment of recurrent urinary tract infections: clinical evidence and guidelines
2013	Belgian Health Care Knowledge Centre (KCE)	General framework for a multidisciplinary quality manual for cardiac care networks
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Nutrition during hospitalization for pediatric bronchiolitis
2013	Blue Cross Blue Shield Association (BCBS)	Special Report: multiple molecular testing of cancers to identify targeted therapies
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Routine blood tests for patients in the intensive care unit: clinical effectiveness, cost-effectiveness, and guidelines
2013	HAYES, Inc.	Dry needling for myofascial pain in adults
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Dexmedetomidine for sedation of cardiac surgical patients
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Swabbing techniques for the detection of bacterial colonization in wounds: comparative clinical evidence and guidelines
2013	Belgian Health Care Knowledge Centre (KCE)	Supportive treatment for cancer – Part 3: Treatment of pain: most common practices
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Nebulized hypertonic saline treatment for infants with bronchiolitis
2013	Blue Cross Blue Shield Association (BCBS)	Breast-Specific Gamma Imaging (BSGI), Molecular Breast Imaging (MBI), or scintimammography with breast-specific gamma camera
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Long term Use of Clopidogrel for Patients with Stents or Acute Coronary Syndrome: A Review of Clinical and Cost-effectiveness and Guidelines
2013	HAYES, Inc.	Endovascular repair of isolated iliac artery aneurysms
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Appropriate use of lumbar fusion surgery
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Management of diabetes in the long-term care population: a review of guidelines
2013	Belgian Health Care Knowledge Centre (KCE)	The decisional process for the choice of active surveillance in localized prostate cancer
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Oxygen saturation discharge thresholds for infants admitted with bronchiolitis
2013	Blue Cross Blue Shield Association (BCBS)	Special Report: exome sequencing for clinical diagnosis of patients with suspected genetic disorders
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Long term use of clopidogrel for patients with stents or acute coronary syndrome: a review of clinical and cost-effectiveness and guidelines
2013	HAYES, Inc.	Extracorporeal shock wave therapy for chronic plantar fasciitis
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Management of back pain following cardiac electrophysiology procedures
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vaginal preparation prior to cesarean delivery: clinical evidence
2013	Belgian Health Care Knowledge Centre (KCE)	Organisation of aftercare for patients with severe burn injuries
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Scales for assessing inpatients' risk of accidental falls
2013	Blue Cross Blue Shield Association (BCBS)	Handheld radiofrequency spectroscopy for intraoperative margin assessment during breast-conserving surgery
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Photo-activated disinfection therapy for non-dental surgery: review of the clinical effectiveness
2013	HAYES, Inc.	Fecal calprotectin assay for management of crohn's disease
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Use of midodrine with vasopressors in the intensive care unit
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Azilsartan Medoxomil + Chlorthalidone (Edarbyclor- Takeda Canada Inc.) indication: severe hypertension
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Frequently-overused technologies
2013	Blue Cross Blue Shield Association (BCBS)	Ocriplasmin for symptomatic vitreomacular adhesion
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hemolysis and blood infusion pumps for patients receiving blood or blood components: standards and evidence-based guidelines: standards and evidence-based guidelines
2013	HAYES, Inc.	Gastric electrical stimulation for gastroparesis
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Physician training and credentialing for robotic surgery in obstetrics and gynecology
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Technologies assisting in remote consultations for the diagnosis of stroke: a review of the clinical evidence
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Routine replacement of peripheral intravenous catheters
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	C1-esterase inhibitor (Berinert®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bariatric surgery for obese patients with co-morbidities: a review of clinical effectiveness, cost-effectiveness, and guidelines
2013	HAYES, Inc.	Laser therapy for psoriasis
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Obstetric early warning systems
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Appropriateness of CT imaging to support the diagnosis of stroke: a review of the clinical evidence
2013	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Study of adherence to Recombinant Growth Hormone treatment of children with a GH deficiency: contributions to treatment control and economic impact
2013	NIHR Health Technology Assessment programme	Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial)
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Controlled medication agreements for opioid use in chronic pain
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Linagliptin/metformin (Jentadueto®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	O-Arm technology in spinal, neurological, orthopedic, or trauma surgery settings: clinical effectiveness and benefits and harms to patients and hospital staff
2013	HAYES, Inc.	Maggot therapy for nonhealing wounds
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Systematic reviews of robotic surgery in obstetrics and gynecology
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Linagliptin-metformin (Jentadueto - Boehringer Ingelheim (Canada) Ltd.) indication: type 2 diabetes mellitus
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Cognitive and procedural skills of aging physicians
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Perampanel (Fycompa®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intraoperative monitoring during spinal or neurological surgeries: clinical effectiveness and guidelines
2013	HAYES, Inc.	Percutaneous pulmonary valve implantation for right ventricular outflow tract defects
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Specialized geriatric care for hospitalized inpatients
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Perampanel (Fycompa - Eisai Ltd.) indication: epilepsy, partial-onset seizures
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Synthetic fleece (Polartec) attire: update
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Aclidinium bromide (Eklira® Genuair®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Indigenous knowledge for mental illness and chronic disease: clinical effectiveness and guidelines
2013	HAYES, Inc.	Photodynamic therapy for head and neck cancer
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Management of patients after the removal of an indwelling urinary catheter
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Azilsartan Medoxomil (Edarbi - Takeda Canada Inc.) indication: mild to moderate essential hypertension
2013	Andalusian Health Technology Assessment Area (AETSA)	[Hemodynamic monitoring techniques in the intensive care units]
2013	NIHR Health Technology Assessment programme	Cancer of Oesophagus or Gastricus - New Assessment of Technology of Endosonography (COGNATE): report of pragmatic randomised trial
2013	Agency for Healthcare Research and Quality (AHRQ)	Epoetin and darbepoetin for managing anemia in patients undergoing cancer treatment: comparative effectiveness update
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Community health workers
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Adalimumab (Humira®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Management of coronary artery disease in primary and community care: guidelines
2013	HAYES, Inc.	Photoscreening for the detection of amblyopia risk factors in children
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Nurse-directed protocols for removal of indwelling urinary catheters
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Distance consultation for chronic, non-healing, lower extremity wounds: clinical evidence
2013	NIHR Health Technology Assessment programme	AESOPS: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users in primary care
2013	Agency for Healthcare Research and Quality (AHRQ)	Childhood obesity prevention programs: comparative effectiveness review and meta-analysis